Registration Opening Soon for BOS Events 2025!

Dates for BOS Events 2025 are confirmed as 11th and 12th June for BOS Basel 2025 and 25th and 26th November for BOS Manchester 2025. Please find further details outlining provisional floor plans and pricing options at the event links provided. Note that we plan to open for registrations on Monday 4th November at 09.00 GMT.

The focus of these events is partnerships in R&D outsourcing with the primary scope being development-stage CMC outsourcing of Small Molecules, Biologics and New Therapeutic Entities.

We continue to evaluate the opportunity for digital events and resources, please look out for an announcement soon on this. We look forward to welcoming you and your colleagues to BOS Events! Please contact the Bio2Business team for further details.

Featured Company (BOS Basel 2024)

Debiopharm International
Debiopharm is an independent biopharmaceutical company based in Switzerland with an ongoing commitment to develop tomorrow’s standard of care to cure cancer & infectious diseases and improve patient quality of life. Our main activities include drug development, drug manufacturing and digital health...
View profile

Featured Speaker (BOS Basel 2024)

Outsourcing of API and Formulation Manufacturing of a Compound with Segregation Needs.

Dr firstname_2218 lastname_2218, Director (Consultant), companyname_2218

ABSTRACT: Investigations compound with segregation needs present a significant challenge in outsourcing the drug substance and drug product production. A handful of CDMOs are available across the globe that can manage these compounds' production, significantly impacting drug development timelines and budgets. In his presentation at BOS Basel 2024, Dr Yogeshwar Bachhav (Director, Consultant) at AiCuris Anti-infective Cures AG, Germany, will highlight the obstacles to outsourcing DS and DP manufacturing for a compound needing segregation while handling Click here to Read More